Graded against 173,636 supplements + 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, NIH DSLD
L-Serine
MODERATE EVIDENCEAmino AcidLast updated
AVELOR SUMMARY
L-serine is a non-essential amino acid that is emerging as a neuroprotective compound. A 2016 Phase I trial found 15-30g/day L-serine slowed ALS progression by 85% (vs historical controls) — now in Phase IIb trials. The mechanism: L-serine prevents misincorporation of L-BMAA (a neurotoxic amino acid from cyanobacteria linked to ALS) into proteins. Also: precursor to D-serine (NMDA co-agonist — essential for synaptic plasticity) and phosphatidylserine. High dietary serine correlates with lower Alzheimer's risk. Dose: 15-30g/day for neurodegeneration (high dose); 500-3,000mg/day as supplement.
---
*Reviewed by the Dose AI Research Team and Clinical Advisory Board*
*Last updated: 2026-04-06*
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.